684-685DOI: 10.17235/reed.2022.8895/2022
Editorial
Lights and shadows in the new definition of steatotic liver disease
DOI: 10.17235/reed.2024.10696/2024
Original
Prognostic value of liver stiffness in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis
DOI: 10.17235/reed.2024.10353/2024
Special Article
Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH-AEG-SEPD-SEOM-GETECCU
DOI: 10.17235/reed.2024.10250/2024
Letter
Hepatocellular carcinoma with tumoral extension to the inferior vena cava and right atrium
DOI: 10.17235/reed.2024.10174/2023
Hepatosplenic schistosomiasis: an uncommon cause of liver disease in developed countries
DOI: 10.17235/reed.2023.10036/2023
Hepatic invasion of a gastric ulcer confirmed by endoscopy and surgery
DOI: 10.17235/reed.2023.9999/2023
A case of complex hemangioendothelioma of the liver in an infant
DOI: 10.17235/reed.2023.9949/2023
Digestive Diseases Image
Extremely giant liver hemangioma: a case beyond the norms
DOI: 10.17235/reed.2023.9877/2023
Liver transplantation in colorectal metastases. Is there an indication for this procedure?
DOI: 10.17235/reed.2023.9873/2023
FIB-4 score as a predictor of COVID-19-related severity in hospitalized patients
DOI: 10.17235/reed.2024.9811/2023
An unusual cause of liver lesions
DOI: 10.17235/reed.2023.9787/2023
Diagnosis and management of Abernethy syndrome
DOI: 10.17235/reed.2023.9781/2023
Is post COVID-19 cholangiopathy an appropriate indication for liver transplantation?
DOI: 10.17235/reed.2023.9740/2023
Fulminant hepatitis due to spontaneous reactivation of virus B in an immunocompetent patient
DOI: 10.17235/reed.2023.9707/2023
Polycystic liver diseases: from molecular basis to development of effective treatments
DOI: 10.17235/reed.2023.9649/2023
Amyloidosis: a rare cause of severe acute liver failure
DOI: 10.17235/reed.2023.9598/2023
Icteric syndrome secondary to polycystic liver disease
DOI: 10.17235/reed.2023.9590/2023
Perivascular epithelioid cell tumor (PEComa) of the liver. An extremely rare diagnosis
DOI: 10.17235/reed.2023.9558/2023
Liver disorders and celiac disease
DOI: 10.17235/reed.2023.9516/2023
Cystic fibrosis with liver involvement in adults has a benign course. Results from a tertiary referral center cohort
DOI: 10.17235/reed.2022.9289/2022
How strong is the evidence to support statins repurposing for the treatment of cirrhosis?
DOI: 10.17235/reed.2022.9281/2022
Ruptured subcapsular liver hematoma as a rare complication of HELLP syndrome. A therapeutic challenge
DOI: 10.17235/reed.2022.9276/2022
Budd-Chiari syndrome in Behçet’s disease
DOI: 10.17235/reed.2022.9267/2022
Non-invasive liver fibrosis assessment: is transient elastography mandatory?
DOI: 10.17235/reed.2022.9214/2022
Successful treatment of Crohn’s disease, aseptic liver abscess and psoriasis with ustekinumab
DOI: 10.17235/reed.2022.9155/2022
Review
Association between platelet indices and non-alcoholic fatty liver disease: a systematic review and meta-analysis
DOI: 10.17235/reed.2022.9142/2022
Hepatic involvement in hereditary hemorrhagic telangiectasia mimicking focal nodular hyperplasia
DOI: 10.17235/reed.2022.9069/2022
Protective measures against Omicron could be more effective than Evusheld® in liver transplant recipients
DOI: 10.17235/reed.2022.9058/2022
Drug induced liver injury by immunotherapy
DOI: 10.17235/reed.2022.9179/2022
Prevalence of non-alcoholic fatty liver disease in pediatric mental disorder inpatients: a tertiary mental health referral hospital study
DOI: 10.17235/reed.2022.8986/2022
The complex management of hepatocellular carcinoma: a major need for expertise
DOI: 10.17235/reed.2022.8953/2022
Everolimus versus mycophenolate mofetil in liver transplantation: every improvement in renal function matters
DOI: 10.17235/reed.2022.8902/2022
Intra-abdominal epithelioid angiosarcoma
DOI: 10.17235/reed.2022.8878/2022
Immunotherapy in hepatocellular carcinoma
DOI: 10.17235/reed.2022.8876/2022
Implementation and impact of an antibiotic control program and multidrug-resistant bacterial colonization in a liver transplant unit
DOI: 10.17235/reed.2022.8810/2022
Probiotics and non-alcoholic fatty liver disease in children and adolescents: a systematic review
DOI: 10.17235/reed.2022.8796/2022
From metastasis to the primary tumor: Giant liver metastasis from a pancreatic neuroendocrine tumor
DOI: 10.17235/reed.2022.8758/2022
Acute liver failure due to anti-tuberculous treatment: when you travel without medical follow-up
DOI: 10.17235/reed.2022.8798/2022
Liver stiffness accuracy by magnetic resonance elastography in histologically proven non-alcoholic fatty liver disease patients: a Spanish cohort
DOI: 10.17235/reed.2022.8777/2022
Liver abscess due to parvimonas micra
DOI: 10.17235/reed.2022.8751/2022
Non-invasive liver fibrosis tests in non-alcoholic fatty liver disease
DOI: 10.17235/reed.2022.8718/2022
Posterior reversible encephalopathy syndrome (PRES) in post liver transplantation
DOI: 10.17235/reed.2022.8694/2022
Hepatic amyloidosis: a prevalence study and clinical characterization of a rare and severe disease
DOI: 10.17235/reed.2022.8622/2022
Ustekinumab for corticodependent immune-mediated colitis by pembrolizumab, an alternative for patients with concomitant liver injury
DOI: 10.17235/reed.2022.8618/2022
MAFLD burden on the Spanish National Health System. A call to action
DOI: 10.17235/reed.2022.8606/2022
Acute pancreatitis: an opportunity for gastroenterology hospitalists?
DOI: 10.17235/reed.2022.8573/2022
Effects of everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study
DOI: 10.17235/reed.2022.8549/2021
Gastric ulcer with liver penetration
DOI: 10.17235/reed.2022.8528/2021
Can NAFLD overwhelm the Spanish healthcare system in the years to come?
DOI: 10.17235/reed.2021.8524/2021
EUS-guided fine-needle liver biopsy in pediatric patients using a modified technique with one-pass, one-actuation wet suction
DOI: 10.17235/reed.2022.8503/2021
Ertapenem neurotoxicity in liver transplantation
DOI: 10.17235/reed.2021.8469/2021
Ischemic cholangiopathy following hepatic artery pseudoaneurysm with thrombosis
DOI: 10.17235/reed.2021.8395/2021
Metabolic syndrome before liver transplantation: does it have an impact on post liver transplantation outcome?
DOI: 10.17235/reed.2022.8384/2021
Giant cystic hepatocarcinoma in the absence of cirrhosis
DOI: 10.17235/reed.2021.8313/2021
Unexpected diagnosis for nodular hepatic lesions
DOI: 10.17235/reed.2021.8230/2021
A new single-use disposable duodenoscope (EXALT™ Model D) for the treatment of an anastomotic biliary stenosis in a liver transplant patient
DOI: 10.17235/reed.2021.8201/2021
Impact of the COVID-19 lockdown on liver transplant recipients. A single center observational study
DOI: 10.17235/reed.2021.8173/2021
Clip migration after cholecystectomy
DOI: 10.17235/reed.2021.8156/2021
“Hot quadrate lobe spot” sign in chronic superior vena cava obstruction
DOI: 10.17235/reed.2021.8154/2021
EBVMCU in a liver-transplant patient
DOI: 10.17235/reed.2021.8064/2021
Mild AST elevation as an early sign of COVID-19 severity in a multicenter Madrid cohort
DOI: 10.17235/reed.2021.8007/2021
Assessment of liver damage in patients with COVID-19 is sub-optimal: results of a survey of medical practitioners
DOI: 10.17235/reed.2021.7970/2021
A review of the diagnosis and management of liver hydatid cyst
DOI: 10.17235/reed.2021.7896/2021
COVID-19 and the liver: the chicken or the egg dilemma
DOI: 10.17235/reed.2021.7861/2021
Hepatic injury and COVID-19: pathogenic mechanisms or epiphenomena?
DOI: 10.17235/reed.2021.7851/2021
Abnormal liver chemistry constitutes an independent prognostic factor of less favorable clinical course in patients with COVID-19
DOI: 10.17235/reed.2021.7842/2021
Characteristics and outcome of incidental hepatocellular carcinoma after liver transplantation: a cohort study
DOI: 10.17235/reed.2021.7744/2020
Percutaneous treatment of a splenorenal shunt with an atrial septal closure device
DOI: 10.17235/reed.2020.7701/2020
Emergency department frequentation and unscheduled readmissions within the first year after liver transplantation, and their impact on survival
DOI: 10.17235/reed.2021.7666/2020
Liver manifestations in COVID-19 and the influence of pre-existing liver disease in the course of the infection
DOI: 10.17235/reed.2020.7627/2020
Inflammatory pseudotumor-like follicular dendritic cell sarcoma of the liver
DOI: 10.17235/reed.2020.7602/2020
Physical frailty in liver transplantation
DOI: 10.17235/reed.2020.7448/2020
Liver transplant in a receptor with ABO incompatibility: a viable option
DOI: 10.17235/reed.2020.7416/2020
Chronic viral hepatitis C micro-elimination program using telemedicine. The Mexican experience
DOI: 10.17235/reed.2020.7425/2020
Impact of liver injury on the severity of COVID-19: a systematic review with meta-analysis
DOI: 10.17235/reed.2020.7397/2020
Long-term outcomes and clinical impact of anti-HLA donor-specific antibodies (DSA) after liver transplantation: a prospective study in a pilot cohort
DOI: 10.17235/reed.2020.7337/2020
Hepatic epithelioid hemangioendothelioma: a rare vascular tumor with an unpredictable diagnosis
DOI: 10.17235/reed.2020.7318/2020
Is gastroparesis that is often detected in patients with alcoholic chronic liver disease a manifestation of an autonomic dysfunction syndrome? A preliminary study
DOI: 10.17235/reed.2020.7303/2020
Hepatic osteodystrophy in cirrhosis due to alcohol-related liver disease
DOI: 10.17235/reed.2020.7301/2020
Acute hepatocellular drug-induced liver injury probably caused by doxazosin
DOI: 10.17235/reed.2020.7268/2020
Alcoholic-related liver disease: pathogenesis, management and future therapeutic developments
DOI: 10.17235/reed.2020.7242/2020
Overall clinical and economic impact of non-alcoholic fatty liver disease
DOI: 10.17235/reed.2020.7238/2020
Acute hepatitis due to olmesartan: an uncommon entity
DOI: 10.17235/reed.2020.7236/2020
Management of hepatic artery aneurysms
DOI: 10.17235/reed.2020.7219/2020
COVID-19 and the digestive system: protection and management during the SARS-CoV-2 pandemic
DOI: 10.17235/reed.2020.7128/2020
Epithelioid hemangioendothelioma: a rare cause of a liver tumor
DOI: 10.17235/reed.2020.7127/2020
Pyroptosis in liver disease
DOI: 10.17235/reed.2020.7034/2020
Paroxysmal nocturnal hemoglobinuria and liver transplantation, a new paradigm
DOI: 10.17235/reed.2020.7167/2020
Changes in the characteristics of hospital admissions due to decompensated cirrhosis in the era of direct-acting antivirals against hepatitis C virus
DOI: 10.17235/reed.2020.7024/2020
Diabetes is not associated with an increased risk of hepatocellular carcinoma in patients with alcoholic or hepatitis C virus cirrhosis
DOI: 10.17235/reed.2020.6953/2020
Biopsy for hepatocellular carcinoma: only occasionally
DOI: 10.17235/reed.2020.6935/2020
Management of chronic liver disease-associated severe thrombocytopenia in Spain: a view from the experts
DOI: 10.17235/reed.2020.6895/2020
Metastatic leiomyosarcoma of the inferior vena cava with long-time survival: therapeutic options
DOI: 10.17235/reed.2020.6863/2020
Urgent left lobectomy as a treatment for broken and infected late subcapsular hepatic hematoma following endoscopic retrograde cholangiopancreatography
DOI: 10.17235/reed.2020.6853/2019
Liver failure caused by Kappa-light chain amyloidosis: a rare case report of multiple myeloma
DOI: 10.17235/reed.2020.6823/2019
Comparison of shear wave elastography (supersonic) with liver biopsy in a cohort of patients from a medium-income country: an observational study
DOI: 10.17235/reed.2020.6816/2019
Quality of care provided to outpatients with hepatic cirrhosis in a teaching hospital
DOI: 10.17235/reed.2020.6811/2019
The outcome of living donor liver transplant recipients with recent episodes of spontaneous bacterial peritonitis
DOI: 10.17235/reed.2020.6780/2019
Radical surgery in hepatic hydatidosis: analysis of results in an endemic area
DOI: 10.17235/reed.2020.6722/2019
Endoscopic treatment of biliary complications after liver transplantation
DOI: 10.17235/reed.2020.6704/2019
Metabolic syndrome, non-alcoholic fatty liver disease and hepatocarcinoma
DOI: 10.17235/reed.2020.6640/2019
The relationship between integrin avß6 and HBV infection in patients with liver cirrhosis and hepatocellular carcinoma: a preliminary report
DOI: 10.17235/reed.2020.6607/2019
A new pattern in hepatitis A virus infection in an urban population
DOI: 10.17235/reed.2020.6526/2019
Case Report
Ectopic hepatocellular carcinoma arising from the peritoneum
DOI: 10.17235/reed.2019.6408/2019
Hepatic epithelioid angiomyolipoma: contribution of a new case
DOI: 10.17235/reed.2019.6388/2019
The efficacy of glucagon-like peptide 1 receptor agonists in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials
DOI: 10.17235/reed.2020.6392/2019
Concurrent hepatic and renal angiomyolipomas in tuberous sclerosis complex
DOI: 10.17235/reed.2020.6376/2019
Elevated high mobility group A2 expression in liver cancer predicts poor patient survival
DOI: 10.17235/reed.2019.6365/2019
Simple liver cyst presenting with clinical signs and symptoms of right-sided heart failure
DOI: 10.17235/reed.2019.6271/2019
Psoriasis and fatty liver: a harmful synergy
DOI: 10.17235/reed.2019.6263/2019
Clinical characteristics and genetic profiles of young and adult patients with cholestatic liver disease
DOI: 10.17235/reed.2019.6168/2019
A giant liver abscess due to Fasciola hepatica infection
DOI: 10.17235/reed.2019.6136/2018
Characteristics and survival of hepatocellular carcinoma in non-cirrhotic liver
DOI: 10.17235/reed.2019.6180/2018
Liver transplantation as a rescue surgery after failure of embolization of a giant hepatic artery pseudoaneurysm
DOI: 10.17235/reed.2019.6223/2018
Analysis of the burden and variability in the management of NAFLD patients in the clinical practice: unifying the required criteria
DOI: 10.17235/reed.2019.6088/2018
HCV eradication with all-oral therapy in cirrhotic HIV-coinfected patients: an observational study of early changes in liver function and fibrosis tests
DOI: 10.17235/reed.2019.6086/2018
Metabolic characterization of two different non-alcoholic fatty liver disease pre-clinical mouse models
DOI: 10.17235/reed.2019.6083/2018
An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesity
DOI: 10.17235/reed.2019.6068/2018
Risk factors differentially associated with non-alcoholic fatty liver disease in males and females with metabolic syndrome
DOI: 10.17235/reed.2019.6031/2018
Bariatric and metabolic endoscopy in the handling of fatty liver disease. A new emerging approach?
DOI: 10.17235/reed.2019.5949/2018
Association between thymosin beta4 and non-alcoholic fatty liver disease
DOI: 10.17235/reed.2019.5927/2018
Spontaneous liver rupture secondary to distal right hepatic artery microaneurysms in a patient admitted due to Staphylococcus aureus pneumonia
DOI: 10.17235/reed.2018.5906/2018
Comparative study of overweight and obese patients with nonalcoholic fatty liver disease
DOI: 10.17235/reed.2019.5926/2018
A liver abscess secondary to a toothpick: a rare complication of accidental foreign body ingestion
DOI: 10.17235/reed.2018.5860/2018
Liver transplantation in patients with type IIIa glycogen storage disease, cirrhosis and hepatocellular carcinoma
DOI: 10.17235/reed.2018.5856/2018
First approaches for the transplantation of hepatocytes from Wistar rat preneoplastic livers into healthy recipients
DOI: 10.17235/reed.2019.5830/2018
Risk factors and impact of portal vein thrombosis in liver transplantation
DOI: 10.17235/reed.2019.5819/2018
Meta-analysis of the diagnostic value of contrast-enhanced ultrasound for the detection of vascular complications after liver transplantation
DOI: 10.17235/reed.2018.5818/2018
Protecting renal function: a relevant decision for liver transplantation
DOI: 10.17235/reed.2018.5836/2018
Fulminant liver failure secondary to submassive hepatic necrosis in a patient treated with Orlistat. A case report
DOI: 10.17235/reed.2018.5740/2018
Asparaginyl endopeptidase may promote liver sinusoidal endothelial cell angiogenesis via PI3K/Akt pathway
DOI: 10.17235/reed.2018.5709/2018
Treatment of graft-versus-host disease with mesenchymal cells as a complication of a liver transplantation
DOI: 10.17235/reed.2018.5672/2018
Intestinal IgA positive lymphocytes in acute liver necrosis decrease due to lymphocyte homing disturbance and apoptosis
DOI: 10.17235/reed.2018.5656/2018
Role of the PNPLA3 polymorphism rs738409 on silymarin + vitamin E response in subjects with non-alcoholic fatty liver disease
DOI: 10.17235/reed.2018.5602/2018
Tumor recurrence after liver transplantation for diffuse biliary papillomatosis in the absence of invasive carcinoma
DOI: 10.17235/reed.2018.5557/2018
Graft survival after liver transplantation: an approach to a new Spanish risk index
DOI: 10.17235/reed.2018.5473/2018
Prevalence and progression of chronic kidney disease after liver transplant: a prospective, real-life, observational, two-year multicenter study
DOI: 10.17235/reed.2018.5431/2017
Giant hepatobiliary cystadenoma: clinic-pathological findings
DOI: 10.17235/reed.2018.5414/2017
Letter to the Editor
Post-transplant lymphoproliferative disease after liver transplantation
DOI: 10.17235/reed.2017.5387/2017
Hepatic encephalopathy secondary to a splenorenal shunt that manifested a long time after a liver transplantation
DOI: 10.17235/reed.2018.5370/2017
Complicated peribiliary cysts in patient without any prior liver disease
DOI: 10.17235/reed.2017.5350/2017
Complete splenic embolization for the treatment of refractory ascites after liver transplantation
DOI: 10.17235/reed.2018.5338/2017
Liver transplantation in hemophilia A and von Willebrand disease type 3: perioperative management and post-transplant outcome
DOI: 10.17235/reed.2018.5204/2017
Spontaneous hepatic rupture in a bodybuilder: a case report and review of the literature
DOI: 10.17235/reed.2017.5103/2017
Efficacy and safety of vedolizumab as a treatment option for moderate to severe refractory ulcerative colitis in two patients after liver transplant due to primary sclerosing cholangitis
DOI: 10.17235/reed.2017.5024/2017
Liver-kidney simultaneous transplantation in adult patients with primary hyperoxaluria. Experience at Hospital Universitario 12 de Octubre
DOI: 10.17235/reed.2017.5016/2017
An intrahepatic cavoportal collateral pathway due to a liver hydatid cyst obstructing the inferior vena cava
DOI: 10.17235/reed.2017.4983/2017
Insulin resistance and the metabolic syndrome are related to the severity of steatosis in the pediatric population with obesity
DOI: 10.17235/reed.2017.4898/2017
Liver metastasis from neuroendocrine carcinoma after the use of the new direct-action antivirals against hepatitis C virus in a patient with past history of hepatocellular carcinoma
DOI: 10.17235/reed.2017.4772/2016
CLIF-C ACLF score is a better mortality predictor than MELD, MELD-Na and CTP in patients with Acute on chronic liver failure admitted to the ward
DOI: 10.17235/reed.2017.4701/2016
Serum thymosin beta4 as a noninvasive biomarker in patients with nonalcoholic steatohepatitis
DOI: 10.17235/reed.2017.4690/2016
Characterization of liver changes in ZSF1 rats, an animal model of metabolic syndrome
DOI: 10.17235/reed.2017.4575/2016
Prognostic factors of liver cirrhosis mortality after a first episode of spontaneous bacterial peritonitis. A multicenter study
DOI: 10.17235/reed.2017.4517/2016
Liver metastasis from colorectal cancer 12 years after liver transplantation
DOI: 10.17235/reed.2017.4507/2016
Hepatocellular carcinoma presenting with Budd-Chiari syndrome, right atrial thrombus and pulmonary emboli
Could viral load combined with indirect serum markers be an option for predicting the degree of liver fibrosis in treatment-naïve chronic hepatitis B patients?
DOI: 10.17235/reed.2016.4439/2016
Methylation status of the estrogen receptor 1 promoter predicts poor prognosis of acute-on-chronic hepatitis B liver failure
DOI: 10.17235/reed.2017.4426/2016
Intrahepatic clear cell cholangiocarcinoma - An uncommon histologic subtype: case report and literature review
DOI: 10.17235/reed.2017.4239/2016
Post-transplant lymphoproliferative disease in liver transplant recipients
DOI: 10.17235/reed.2017.4228/2016
Prevalence and outcome of portal thrombosis in a cohort of cirrhotic patients undergoing liver transplantation
DOI: 10.17235/reed.2016.4211/2016
Hepatic preneoplasia induction in male Wistar rats: histological studies up to five months post treatment
DOI: 10.17235/reed.2016.4183/2015
The clinical extremes of autoimmune cholangitis
DOI: 10.17235/reed.2017.4167/2015
Indication for liver transplantation in a patient with a history of a gastric lymphoma
DOI: 10.17235/reed.2016.4191/2015
Evaluation of large esophageal varices in cirrhotic patients by transient elastography: a meta-analysis
DOI: 10.17235/reed.2016.3980/2015
Overexpression of Aquaporin 1 on cysts of patients with polycystic liver disease
DOI: 10.17235/reed.2015.3960/2015
Epithelioid angiomyolipoma of the liver: Clinicopathological correlation in a series of 4 cases
DOI: 10.17235/reed.2015.3947/2015
Glycogenic hepatopathy in young adults: a case series
DOI: 10.17235/reed.2016.3934/2015
The diagnostic value of a globulin/platelet model for evaluating liver fibrosis in chronic hepatitis B patients
DOI: 10.17235/reed.2015.3851/2015
Recurrence of liver metastases from colorectal cancer and repeat liver resection
DOI: 10.17235/reed.2015.3843/2015
Spontaneous rupture of a liver hemangioma. A case report
Recurrent drug-induced liver injury (DILI) with ciprofloxacin and amoxicillin/clavulanic
DOI: 10.17235/reed.2015.3810/2015
Liver failure posthepatectomy and biliary fistula: multidisciplinar treatment
DOI: 10.17235/reed.2015.3747/2015
Liver abscess secondary to duodenal perforation by fishbone: Report of a case
Graft versus host disease as a complication after liver transplantation: A rare but serious association
DOI: 10.17235/reed.2015.3722/2015
Solitary fibrous tumor of the liver. Case report and review of the literature
DOI: 10.17235/reed.2015.3676/2014
Severe acute liver failure and thyrotoxicosis: an unusual association
DOI: 10.17235/reed.2015.3607/2014
Leiomyosarcoma of the ascending colon: a rare tumor with poor prognosis
DOI: 10.17235/reed.2015.3606/2014
PITAVASTATIN: OTHER STATIN TO BE USED AND MONITORED
DOI: 10.17235/reed.2015.3565/2014
Liver abscess by Eikenella Corrodens
DOI: 10.17235/reed.2015.3613/2014
Leiomyoma of the round ligament of the liver: Report of one case
DOI: 10.17235/reed.2015.3725/2014
Download the citation for this article by clicking on one of the following citation managers:
Received: 30/04/2022
Accepted: 03/05/2022
Online First: 12/05/2022
Published: 07/11/2022
Article Online First time: 12 days
Article editing time: 191 days
Submission and tracking
Access to the information published on the website (www.reed.es) of the Sociedad Española de Patología Digestiva (SEPD), Calle Sancho Dávila, 6, 28028 Madrid, CIF: G28486280, telephone: 914021353, e-mail: sepd@sepd.es, implies acceptance of the following conditions of use:
1. The SEPD published its website in order to make it easier for potential visitors to access information related to its services. The information displayed on this website is made available to users accessing the website, both privately and individually, at no additional cost. The commercialization of access rights is expressly prohibited.
2. It is expressly forbidden to copy or reproduce the information published by means of any electronic medium (web pages, databases, web pages or electronic publications) that allows the dissemination of any information published on this website to multiple users without the prior written consent of the SEPD.
3. Accuracy of information: The SEPD endeavors to display accurate and up-to-date information on its website. However, the SEPD is not responsible for the consequences of reading this information.
4. SEPD is not liable for any damages that the user may cause in connection with access to this website or the use of its contents.
5. Notice to users and/or patients: The information included in www.reed.es is for the exclusive use of healthcare professionals and this will be stated in the registration and access alert.
6. Funding: REED, the official scientific body of the EDPS, shares the same sources of funding as the EDPS, as laid down in Article 22, SECTION VII (ECONOMIC AND DOCUMENTARY SYSTEM) of the EDPS's Statutes.
The website http://www.reed.es may host advertising from third parties that may be considered of interest to the user and in no way a source of budgetary funding for the website. Wherever the word 'Advertising' is displayed, it will be highlighted.
However, advertising that infringes Law 29/2006 on guarantees and rational use of medicines and health products will not be accepted. Likewise, there will be no advertising of any kind in those areas of the website where there may be a conflict of interest.
Advertisers have no rights over their editorial content.
7. Access to restricted areas: In relation to access to restricted areas where the user voluntarily completes the registration form, the EDPS will assign the user a password which will be sent to the e-mail address provided by the user, who must make diligent use of the password and keep it secret. Consequently, the user accepts that he/she is responsible for the correct custody and confidentiality of the password/identifier provided by the EDPS. Furthermore, the user shall not provide access to third parties, either temporarily or permanently, or allow access to third parties.
Consequently, the user is solely responsible for all accesses, contents and actions he/she carries out in connection with his/her user ID and access code, with full indemnity for the EDPS.
On this basis, the user is responsible for immediately informing the EDPS of any factors that allow the misuse of the IDs and/or passwords, such as theft, loss or unauthorized access, in order to cancel them immediately. Until such incidents are reported, SEPD will not be liable for any liability that may arise from the misuse of identifiers or passwords by unauthorized third parties.
The user understands and accepts that he/she is accessing a website with content intended exclusively for medical staff and acknowledges that he/she is a healthcare professional.
Notes of interest to members and visitors to the EDPS website: The data and information contained in all content on these websites are only guidance documents for members and are therefore not legally binding.
8. License for public use of the website: is governed by Spanish law, regardless of the country in which the user accesses the website. Any controversy that may arise in the interpretation of these rules of access will be resolved before the Spanish Courts and Tribunals.
Copyright and Creative Commons POR NC ND: The total or partial reproduction of texts and graphics by any means is prohibited without the express written authorization of the EDPS. To insert these texts, images or news items in the publication or dissemination in any medium of any kind accessible to third parties, the express written consent of the EDPS must be obtained.
The private use of the texts, news and data published on this website is strictly for personal purposes.
The General Data Protection Regulation (Regulation (EU) 2016/679) harmonizes Data Protection legislation across the European Union, increasing the protection of individuals and giving them greater control over their personal data.
At the Spanish Society of Digestive Pathology (SEPD), we have always been concerned about the protection of personal data. We have therefore updated our Privacy Policy in order to bring it into line with the new regulations and to inform you of the changes that affect your rights:
Responsible for the processing of your personal data: SOCIEDAD ESPAÑOLA DE PATOLOGÍA DIGESTIVA (SEPD), CIF: G28486280 and registered office at Calle Sancho Dávila 6, 28028 Madrid.
The data collected by the Sociedad Española de Patología Digestiva (SEPD) are obtained in different ways (website, e-mail, electronic forms or on paper) through its activity as a business association and service provider; these data will become part of an information file for which it is responsible.
Purpose of data collection:
Legitimacy of the processing:
Recipients of the data.
Data subjects:
Everyone can know whether or not the EDPS processes their personal data. They have the right to:
SEPD will cease to process the data, except for legitimate reasons, or for the exercise or defense of possible claims.
Origin of the data: SEPD will obtain personal data directly from the data subject through the following communication channels:
Categories of data:
Sending of commercial communications: In accordance with the LSSI, Law 34/2002, and Law 29/2009, of 30 December, if you do not wish to receive any more commercial communications, please send an e-mail with the word BAJA (unsubscribe) to the following address: sepd@sepd.es.
Security measures: SEPD informs that it has adopted all necessary security measures to prevent theft, alteration or unauthorized access to data, taking into account the state of the art, the costs of implementation, the nature, scope, context and purpose of the processing, as well as the variable risks of probability and severity to the rights and freedoms of individuals, such as in cases of outsourced services, request and ensure that the controller implements appropriate technical and organizational measures to ensure an adequate level of security against existing threats, as stated in art. 32 of the Data Protection Regulation.
Exercise of rights:
Everyone has the right to know whether the EDPS processes his or her personal data. He or she also has the right to:
Access their personal data,
Request the rectification of inaccurate data.
Request deletion when, among other reasons, the data are no longer necessary for the purposes for which they were collected.
Object to the processing of your data, on grounds relating to your particular situation, by requesting that they not be processed by the EDPS.
In certain circumstances, request the restriction of the processing of your data, in which case they will only be kept for the exercise or defense of claims.
Withdraw, at any time, the consent given, without this affecting the lawfulness of the processing that we have carried out prior to such withdrawal.
The interested party may exercise their rights at the following address: Sociedad Española de Patología Digestiva (SEPD), c/ Calle Sancho Dávila, 6 28028 Madrid, or by email to the following address: sepd@sepd.es, any controversy that may arise in the interpretation of these access rules will be resolved before the Spanish Courts and Tribunals.
Remember that whenever you exercise any of the rights set out above, you must accompany your request with a copy of your ID card or equivalent document that allows us to verify your identity.
Likewise, if you are not satisfied with how we have dealt with your rights, you may file a complaint with the Spanish Data Protection Agency, through the website www.aepd.es.
The following table describes in detail the cookies present on the website
The user has also been informed of the cookies used by this website by means of the banner that appears on the home screen during the first browsing visit to this website, in which the user can configure them at their own discretion, requesting their consent and management.
A cookie is a small piece of information, usually a few kilobytes to several megabytes in size, which is stored on your terminal when you visit our website. The cookie is used to remember your preferences and other information about your browsing history of our website.
Cookies can be first-party or third-party cookies. This varies depending on whether the cookies are sent to your terminal from a computer or domain managed by us (own cookies), or are sent from a computer or domain not managed by us (third party cookies). They can remain active from a few minutes to several years, or only during the session.
Cookies can have many purposes and sometimes several are grouped together. In addition, there is a group of technical cookies that are necessary for the proper functioning of website, being mandatory to obtain consent for the rest of the cookies with different purposes. Depending on their purpose we can distinguish,
If you wish, you can also manage cookies through your browser. Most browsers are set by default to accept cookies, but you can change the settings to block, delete and manage some or all cookies if you prefer. Please be aware of the possible changes that can occur when deleting or blocking cookies.
Chrome:
https://support.google.com/chrome/answer/95647?hl=es
Explorer:
https://support.microsoft.com/es-es/topic/eliminar-y-administrar-cookies-168dab11-0753-043d-7c16-ede5947fc64d
Edge:
https://support.microsoft.com/es-es/microsoft-edge/eliminar-las-cookies-en-microsoft-edge-63947406-40ac-c3b8-57b9-2a946a29ae09
Safari:
- Ipad, Iphone, Ipod Touch: https://support.apple.com/es-es/HT201265
- Mac: Preferencias, Panel de privacidad
Firefox:
https://support.mozilla.org/es/kb/Borrar%20cookies